Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
Clinical trial NCT04119336 · TERMINATED
Trial details
- NCT number
- NCT04119336
- Sponsor
- Andrew Yee, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-14
- Primary completion
- 2020-11-12
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.